Other
Other Comprehensive Income (Loss)
West Pharmaceutical Services Other Comprehensive Income (Loss) decreased by 5.8% to $119.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.4%, from $142.40M to $119.10M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026Apr 23, 2026
How to read this metric
A large positive value suggests favorable currency or market movements, while a large negative value indicates potential future volatility in equity.
Detailed definition
This represents the aggregate of all items of other comprehensive income or loss, which are excluded from net income und...
Peer comparison
Standardized across all public companies under GAAP/IFRS reporting requirements.
Metric ID:
tmusz_other_comprehensive_income_lossHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $151.00M | -$100.00K | -$100.00K | $0.00 | -$100.00K | $0.00 | -$100.00K | $86.70M | $216.60M | $142.40M | $248.60M | $126.40M | $119.10M |
| QoQ Change | — | — | — | -100.1% | +0.0% | +100.0% | — | +100.0% | — | >999% | +149.8% | -34.3% | +74.6% | -49.2% | -5.8% |
| YoY Change | — | — | — | — | — | -100.0% | +0.0% | +100.0% | — | >999% | — | >999% | +186.7% | -41.6% | -16.4% |
Range-$100.00K – $248.60M
Avg YoY Growth>999%
Median YoY Growth+50.0%
Current Streak2 quarters decline
Other Comprehensive Income (Loss) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other comprehensive income (loss)?
- West Pharmaceutical Services (WST) reported other comprehensive income (loss) of $119.10M in Q1 2026.
- How has West Pharmaceutical Services's other comprehensive income (loss) changed year-over-year?
- West Pharmaceutical Services's other comprehensive income (loss) decreased by 16.4% year-over-year, from $142.40M to $119.10M.
- What does other comprehensive income (loss) mean?
- The total of all gains and losses that are recorded directly in equity rather than through the income statement.